dc.contributor.author | Brusselle, Guy | |
dc.contributor.author | Price, David | |
dc.contributor.author | Gruffydd-Jones, Kevin | |
dc.contributor.author | Miravitlles, Marc | |
dc.contributor.author | Keininger, Dorothy L | |
dc.contributor.author | Stewart, Rebecca | |
dc.contributor.author | Baldwin, Michael | |
dc.contributor.author | Jones, Rupert C | |
dc.date.accessioned | 2015-12-03T12:02:01Z | |
dc.date.available | 2015-12-03T12:02:01Z | |
dc.date.issued | 2015 | |
dc.identifier | 59573222 | |
dc.identifier | 9b42227f-a8e3-4c88-a2dd-d66129ea749d | |
dc.identifier | 26527869 | |
dc.identifier | 84944880515 | |
dc.identifier.citation | Brusselle , G , Price , D , Gruffydd-Jones , K , Miravitlles , M , Keininger , D L , Stewart , R , Baldwin , M & Jones , R C 2015 , ' The inevitable drift to triple therapy in COPD : an analysis of prescribing pathways in the UK ' , International journal of chronic obstructive pulmonary disease , vol. 10 , no. 1 , pp. 2207-2217 . https://doi.org/10.2147/COPD.S91694 | en |
dc.identifier.issn | 1176-9106 | |
dc.identifier.uri | http://hdl.handle.net/2164/5280 | |
dc.description | Acknowledgments The analyses reported in this study were funded by Novartis Pharma AG (Basel, Switzerland) and were conducted by Research in Real-Life Ltd (Cambridge, UK), an independent company. The authors also thank David Bergin, Danielle Corbett, and Vivek Khanna (professional medical writers; Novartis) for assistance in the preparation of this paper. Writing support was funded by Novartis Pharma AG. | en |
dc.format.extent | 11 | |
dc.format.extent | 644890 | |
dc.language.iso | eng | |
dc.relation.ispartof | International journal of chronic obstructive pulmonary disease | en |
dc.subject | chronic obstructive pulmonary disease | en |
dc.subject | GOLD guidelines | en |
dc.subject | observational study | en |
dc.subject | prescribing patterns | en |
dc.subject | primary care | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | The inevitable drift to triple therapy in COPD : an analysis of prescribing pathways in the UK | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.2147/COPD.S91694 | |